This was the stock's second consecutive day of losses.

This was the stock's third consecutive day of gains.

IDEXX Laboratories, Inc. (NASDAQ: IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market return.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published its 2023 Corporate Responsibility Report "Enhancing the Health and Well-being of Pets, People ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline ...

Return on Assets (ROA): IDEXX Laboratories's ROA stands out, surpassing industry averages. With an impressive ROA of 7.13%, the company demonstrates effective utilization of assets and strong ...

In the last 3 months, 5 analysts have offered 12-month price targets for IDEXX Laboratories. The company has an average price target of $562.6 with a high of $600.00 and a low of $530.00.

Idexx Laboratories tested more than 3,500 dogs, cats and horses for the coronavirus that leads to COVID-19. To date, zero have tested positive.

IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and ...

All of the equipment is marked with an ‘IDEXX’ logo. Read More Mum's 15-minute run as she chased thief who snatched £130 Ralph Lauren handbag ...

To be one of them, just click here . Lee Samaha has no position in any stocks mentioned. The Motley Fool recommends Idexx Laboratories. Try any of our Foolish newsletter services free for 30 days .